Hematologic Malignancy Translational Working Group
The Hematologic Malignancy Working Group connects the basic, translational and clinical researchers to enhance their innovation, creativity and productivity. Our members are active investigators in the area of leukemia, lymphoma, multiple myeloma and other cancers of the blood and bone marrow. Our group focuses on promoting collaborations and increasing external funding. We provide a forum for investigators to share their research, vet new ideas and prioritize a research portfolio and invite new partnerships.
In clinical areas, we work together to develop and adhere to comprehensive and innovative algorithms for diagnosis and treatment of hematologic malignancies and invite investigator initiated clinical trials.
HMTW members have access to the Hematologic Malignancy Tissue Bank, which supports robust comprehensively annotated bio-repository of primary marrow and blood samples from patients with hematologic malignancies.
Michael Farrar, PhD
Last Friday of the month; MCRB 450 @ 1-2 p.m
If you would like to attend, please contact Karen Fitz.